Fig. 2
From: Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question
Geographical location of HPTN052, Temprano and START. Source Adapted from a Wikipedia map from http://www.vectorworldmap.com/; public domain. Asterisks recruitment for the START trial in Europe: Germany 7 %, United Kingdom 7 %, Spain 5 %, Belgium 2 %, France 2 %, Greece 2 %, Denmark 1 %, Italy 1 %, Poland 1 %, Portugal 1 %, Switzerland 1 %, others (Czech republic, Estonia, Finland, Luxemburg, Norway, Sweden, Ireland, all <1 %)